12
1
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37562 |
C16 Ceramide
N-acylsphingosine,C16 Ceramide (d18:1/16:0),Palmitoyl Ceramide,N-Palmitoylsphingosine |
p53 | Apoptosis |
C16 Ceramide (Palmitoyl Ceramide) 是一种天然小分子,通过直接选择性结合激活 p53。 | |||
T85197 |
C16 Ceramide-1-phosphate (d18:1/16:0) (ammonium salt)
CerP(d18:1/16:0),C16 Ceramide-1-phosphate,Ceramide-1-phosphate (d18:1/16:0),C16 C1P |
Others | Others |
T69361 |
C16-Urea-Ceramide
|
Others | Others |
C16-Urea-Ceramide s a neutral ceramidase (nCDase) inhibitor. It is a bioactive ceramide. | |||
T85284 |
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0)
N-(2'-(S)-hydroxypalmitoyl)-D-erythro-Sphingosine,2'(S)-hydroxy Cer(d18:1/16:0),2'-hydroxy C16-Ceramide,(2'(S)-hydroxy) Ceramide (d18:1/16:0),16:0 (2S-OH)-Ceramide |
Others | Others |
T37454 |
C16 dihydro Ceramide (d18:0/16:0)
N-Palmitoyl Sphinganine,Cer(d18:0/16:0),N-hexadecanoyl-D-erythro-Dihydrosphingosine,C16 dihydroceramide,Ceramide (d18:0/16:0) |
Others | Others |
C16 dihydro Ceramide (d18:0/16:0) (Cer(d18:0/16:0)) 是合成神经酰胺的前体,诱导核周区域自噬,可用于研究细胞膜的稳定性和神经系统疾病。 | |||
T74304 |
C16 PEG-Ceramide
|
Others | Others |
C16 PEG-Ceramide为一种聚乙二醇化神经酰胺,具备脂质载体传递功能,并能诱导自噬(autophagy),在癌症研究中有应用。 | |||
T85052 |
C16 1-Deoxyceramide (m18:1/16:0)
C16:0 Ceramide (m18:1/16:0),Cer(m18:1/16:0),C16:0 1-Deoxyceramide,N-Hexadecanoyl-1-deoxy-4,5-dihydro-Sphingosine |
Others | Others |
T85175 |
C16((±)-2'-hydroxy) dihydro Ceramide (d18:0/16:0)
N-(R,S)-α-hydroxyhexadecanoyl-D-erythro-Dihydrosphingosine,(±)-2'-hydroxy Ceramide (d18:0/16:0) |
Others | Others |
T37563 |
C22 Ceramide (d18:1/22:0)
Cer(d18:1/22:0),C22 Ceramide,Ceramide (d18:1/22:0) |
||
C22 Ceramide (d18:1/22:0) (C22 Ceramide) 是一种从海绵Haliclona koremella 中分离出含有山嵛酸的长链神经酰胺,是一种内源性生物活性鞘脂。C22 Ceramide (d18:1/22:0) 可特异性抑制MCSR,降低离体大鼠肝线粒体和脂质体中 C16-神经酰胺通道的形成。 | |||
T37872 |
C16 Galactosylceramide (d18:1/16:0)
C16 Galactosylceramide (d18:1/16:0) |
Others | Others |
C16 Galactosylceramide is a glycosphingolipid that contains a galactose moiety attached to a ceramide acylated with palmitic acid . | |||
T36468 |
ARN14988
|
Others | Others |
ARN14988 is a potent inhibitor of acid ceramidase (IC50 = 12.8 nM for the human enzyme). It inhibits acid ceramidase activity and increases levels of C16 dihydro ceramide and C16 ceramide in A375, G361, M14, MeWo, MNT-1, and SK-MEL-28 melanoma cells. ARN14988 also reduces growth of A375 and G361 melanoma cells (EC50s = 41.8 and 67.7 μM, respectively). | |||
T36321 |
C6 Urea Ceramide
|
Others | Others |
C6 urea ceramide is an inhibitor of neutral ceramidase.1 It increases total ceramide levels in wild-type mouse embryonic fibroblasts (MEFs) and in HT-29 colon cancer cells but not in MEFs lacking neutral ceramidase. It inhibits proliferation of, and induces apoptosis and autophagy in HT-29, but not non-cancerous RIE-1, cells when used at concentrations of 5 and 10 μM. C6 urea ceramide decreases total β-catenin, increases phosphorylated β-catenin, and induces colocalization of β-catenin with the ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T82572 |
D-Glucosyl-β-1,1′-N-palmitoylsphingosine
C16 Glucosyl(β) Ceramide (d18:1/16:0) |
Others | Others |
D-Glucosyl-β-1,1′-N-palmitoylsphingosine (C16 Glucosyl(β) Ceramide (d18:1/16:0)) 是内源性Mincle配体,具免疫刺激活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0131 |
C16 Ceramide-d7
|
||
C16 Ceramide-d7 是 C16 Ceramide 的氘代化合物。 | |||
T36149 |
13C C16 Sphingomyelin (d18:1/16:0)
|
||
13C C16 Sphingomyelin is an isotopically enriched form of C16 sphingomyelin with carbon-13 occurring on the fatty acid portion. It is intended for use as an internal standard for the quantification of C16 sphingomyelin by GC- or LC-MS. C16 Sphingomyelin is a form of sphingomyelin containing palmitate (16:0) at the variable acylation position. It is the most common form of sphingomyelin found in eggs and is less abundant in the brain and in milk. C16 Sphingomyelin interacts with cholesterol in or... |